Argenx
ARGX
$368.60
Share price
-1.71%
Change (1 day)
-5.61%
Change (1 year)
Categories
Argenx is a Dutch company that develops antibody therapies to fight autoimmune diseases and cancer.
EPS for Argenx (ARGX)
EPS in 2023 (TTM): -$4.16
According to Argenx 's latest financial reports the company's current EPS (TTM) is -$4.16. In 2022 the company made an earnings per share (EPS) of -$13.12.
EPS history for Argenx from 2022 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.16 | -68.29% |
| 2022 | -$13.12 |